Pharvaris
PHVS
25 hedge funds and large institutions have $380M invested in Pharvaris in 2021 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 5 closing their positions.
3.79% less ownership
Funds ownership: 69.08% → 65.29% (-3.8%)
6% less capital invested
Capital invested by funds: $406M → $380M (-$26M)
11% less funds holding
Funds holding: 28 → 25 (-3)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
38% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 8
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$9.85M |
| 2 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$5.27M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$935K |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$600K |
| 5 |
Goldman Sachs
New York
|
+$40.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$7.45M |
| 2 |
VA
VR Adviser
New York
|
-$5.99M |
| 3 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$5.08M |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$1.49M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$1.29M |
PHVS Hedge Fund Activity: Q3 2021 in Review
25 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Pharvaris (PHVS) for Q3 2021, worth a combined $380M — down 6.4% from $406M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of PHVS and 3 opened new positions — a net loss of 2 holders — while 8 trimmed existing stakes and 5 added.
The largest buyer was Deerfield Management, adding an estimated $9.85M. The largest seller was Avidity Partners Management, exiting entirely with an estimated $7.45M sold.
- 25 institutional investors held Pharvaris (PHVS) as of Q3 2021, down from 28 in Q2 2021.
- Funds reported $380M of Pharvaris stock for Q3 2021, down 6.4% quarter-over-quarter.
- 3 funds opened new Pharvaris positions in Q3 2021 and 5 closed out, a net change of -2 holders.
- The largest Pharvaris buyer in Q3 2021 was Deerfield Management, an estimated $9.85M added.
- The largest Pharvaris seller in Q3 2021 was Avidity Partners Management, an estimated $7.45M sold.
Based on aggregated 13F filings for Q3 2021.